Cargando…
The expression and clinical significance of TPM4 in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is known as the fifth most common cancer in the world for its poor prognosis. New diagnostic markers and treatments are urgent to discover. To evaluate the protein expression of Tropomyosin4 (TPM4) and investigate its prognostic value in HCC, we collected 110 patients...
Autores principales: | Li, Linjing, Ye, Tao, Zhang, Qingyan, Li, Xin, Ma, Li, Yan, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738955/ https://www.ncbi.nlm.nih.gov/pubmed/33390785 http://dx.doi.org/10.7150/ijms.49906 |
Ejemplares similares
-
EIF5A expression and its role as a potential diagnostic biomarker in hepatocellular carcinoma
por: Li, Linjing, et al.
Publicado: (2021) -
The prognostic value of TPM1–4 in hepatocellular carcinoma
por: Tian, Zhihui, et al.
Publicado: (2021) -
MicroRNA-5195-3p mediated malignant biological behaviour of insulin-resistant liver cancer cells via SOX9 and TPM4
por: Yan, Jing, et al.
Publicado: (2023) -
ORMDL3 expression in ASM regulates hypertrophy, hyperplasia via TPM1 and TPM4, and contractility
por: Pham, Alexa K., et al.
Publicado: (2021) -
The effects of crizotinib in a transgenic Drosophila model expressing the human TPM4-ALK fusion gene or TPM4
por: Kim, Yoo Jin, et al.
Publicado: (2019)